Stock ARGX ARGENX SE
Add to a list
To use this feature you must be a member
Log inSign up

Funds and ETFs argenx SE

Equities

ARGX

NL0010832176

Biotechnology & Medical Research

Market Closed - Euronext Bruxelles
Other stock markets
 11:35:13 2024-04-25 am EDT 		After market 11:55:09 am
346.2 EUR -1.06% Intraday chart for argenx SE 347 +0.22%
Apr. 17 European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading MT
Apr. 16 Argenx SE Announces Data from its Phase 3 ADHERE Trial Evaluating VYVGART Hytrulo in Patients with Chronic Inflammatory Demyelinating Polyneuropathy CI

ETFs positioned on argenx SE

Name Weight AuM 1st Jan change Investor Rating
VANECK SUSTAINABLE EUROPEAN EQUAL WEIGHT UCITS ETF - EUR ETF VanEck Sustainable European Equal Weight UCITS ETF - EUR
1.13% 49 M€ +4.53%
HAN-GINS TECH MEGATREND EQUAL WEIGHT UCITS ETF - USD ETF HAN-GINS Tech Megatrend Equal Weight UCITS ETF - USD
0.93% 96 M€ -1.75%
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY ETF Nomura NEXT FUNDS International Equity MSCI-KOKUSAI (Yen-Hedged) ETF - JPY
0.46% 18 M€ +3.04% -
AMUNDI MSCI EUROPE EX UK UCITS ETF (C) - EUR ETF AMUNDI MSCI EUROPE EX UK UCITS ETF (C) - EUR
0.27% 6 M€ -.--% -
UBS (IRL) ETF PLC MSCI EUROPE ESG UNIVERSAL LOW CARBON SELECT UCITS ETF - ACC - EUR ETF UBS (Irl) ETF plc MSCI Europe ESG Universal Low Carbon Select UCITS ETF - Acc - EUR
0.19% 6 M€ -.--%
SIMPLIFY DEVELOPED EX-US PLUS DOWNSIDE CONVEXITY ETF - USD ETF Simplify Developed Ex-US Plus Downside Convexity ETF - USD
0.16% 10 M€ -3.35% -
JPMORGAN ACTIVEBUILDERS INTERNATIONAL EQUITY ETF - USD ETF JPMorgan ActiveBuilders International Equity ETF - USD
0.14% 29 M€ +8.37% -
AMUNDI MSCI WORLD CLIMATE PARIS ALIGNED PAB UCITS ETF DR (C) - USD ETF AMUNDI MSCI WORLD CLIMATE PARIS ALIGNED PAB UCITS ETF DR (C) - USD
0.06% 284 M€ -.--%
LEVERAGE SHARES 3X LONG TOTAL WORLD ETP SECURITIES - USD ETF Leverage Shares 3x Long Total World ETP Securities - USD
0.05% 0 M€ 0.00% -
AMUNDI INDEX MSCI WORLD UCITS ETF - EUR ETF AMUNDI INDEX MSCI WORLD UCITS ETF - EUR
0.05% 1,166 M€ +0.26% -
AMUNDI INDEX MSCI WORLD UCITS ETF DR (D) - EUR ETF AMUNDI INDEX MSCI WORLD UCITS ETF DR (D) - EUR
0.05% 607 M€ +0.05% -
AMUNDI MSCI WORLD CLIMATE TRANSITION CTB UCITS ETF DR (C) - EUR ETF AMUNDI MSCI WORLD CLIMATE TRANSITION CTB UCITS ETF DR (C) - EUR
0.05% 786 M€ -.--%
AMUNDI MSCI WORLD CLIMATE TRANSITION CTB UCITS ETF DR (C) - USD ETF AMUNDI MSCI WORLD CLIMATE TRANSITION CTB UCITS ETF DR (C) - USD
0.05% 23 M€ -.--% -
LYXOR MSCI WORLD CLIMATE CHANGE (DR) UCITS ETF - ACC - USD ETF Lyxor MSCI World Climate Change (DR) UCITS ETF - Acc - USD
0.04% 206 M€ -.--%
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (UNHEDGED) ETF - JPY ETF Nomura NEXT FUNDS International Equity MSCI-KOKUSAI (Unhedged) ETF - JPY
0.04% 273 M€ +14.37%
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF - DISTRIBUTING - EUR ETF Vanguard LifeStrategy 80% Equity UCITS ETF - Distributing - EUR
0.03% 34 M€ +5.94% -
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF ACC - EUR ETF Vanguard LifeStrategy 80% Equity UCITS ETF Acc - EUR
0.03% 389 M€ +4.94% -
IMGP RBA RESPONSIBLE GLOBAL ALLOCATION ETF - USD ETF iMGP RBA Responsible Global Allocation ETF - USD
0.03% 7 M€ +0.11% -
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - ACC - EUR ETF Vanguard LifeStrategy 60% Equity UCITS ETF - Acc - EUR
0.02% 302 M€ +2.88% -
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - DISTRIBUTING - EUR ETF Vanguard LifeStrategy 60% Equity UCITS ETF - Distributing - EUR
0.02% 39 M€ +3.93% -
VANGUARD LIFESTRATEGY 40% EQUITY UCITS ETF ACC - EUR ETF Vanguard LifeStrategy 40% Equity UCITS ETF Acc - EUR
0.02% 108 M€ +1.18% -
VANGUARD LIFESTRATEGY 40% EQUITY UCITS ETF - DISTRIBUTING - EUR ETF Vanguard LifeStrategy 40% Equity UCITS ETF - Distributing - EUR
0.02% 17 M€ +1.15% -
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD ETF Unlimited HFND Multi-Strategy Return Tracker ETF - USD
0.01% 34 M€ +2.35% -
12

Company Profile

argenx SE is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx SE aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx SE is evaluating efgartigimod in multiple serious autoimmune diseases, and cusatuzumab in hematological cancers in collaboration with Janssen. argenx SE is also advancing several earlier stage experimental medicines within its therapeutic franchises. argenx SE has offices in Belgium, the United States, and Japan.
Sector
Biotechnology & Medical Research
Calendar
2024-05-07 - Annual General Meeting
Related indices
STOXX EUROPE 600 (EUR) , BEL-20
More about the company

Income Statement Evolution

More financial data

Ratings for argenx SE

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
349.9 EUR
Average target price
439.3 EUR
Spread / Average Target
+25.55%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
ARGENX SE Stock argenx SE
+0.79% 22.2B
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-3.21% 104B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.89% 97.42B
BIONTECH SE Stock BioNTech SE
-17.97% 21.23B
GENMAB A/S Stock Genmab A/S
-11.11% 18.33B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-42.83% 16.35B
BEIGENE, LTD. Stock BeiGene, Ltd.
-16.66% 15.06B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.81% 13.98B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+31.47% 11.66B
LEGEND BIOTECH CORPORATION Stock Legend Biotech Corporation
-25.88% 8.22B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. ARGX Stock
  4. Funds and ETFs argenx SE